Featured series 
Tag: Vaccine
-
Health
Vaccines may arrive in record time, but the virus has been faster
Vaccines that might protect against COVID-19 have entered phase 3 trials — the last step before regular approval in humans — in record time, but the virus has moved faster, experts say.
-
Health
The risks of ‘not trying enough’ against COVID-19
Harvard economist and former Treasury Secretary Lawrence Summers said we’re in greater danger of doing too little to fight COVID-19 than too much.
-
Health
Vaccines can protect against COVID-19 in nonhuman primates, study says
Harvard-affiliated Beth Israel Deaconess Medical Center has developed vaccines — currently being tested in animal models — that are designed to train the body’s immune system to recognize the virus swiftly upon exposure and respond quickly to disable it.
-
Campus & Community
$16.5 million awarded to projects to fight COVID
MassCPR, a coalition of regional scientific institutions united to fight COVID-19, is awarding $16 million to 62 research projects with the promise to impact patient care within a year.
-
Health
How far are we from a vaccine? Depends on who ‘we’ is
Rising nationalism and global inequity will be hurdles to the distribution of COVID vaccines, despite the comparatively “lightning” fast scientific response to the pandemic so far, a Harvard infectious disease expert said Thursday.
-
Health
Designing a coronavirus vaccine
In response to this public health crisis, researchers in the Precision Vaccines Program at Boston Children’s Hospital are on the front lines of developing a vaccine specially targeted toward older populations
-
Health
A ‘call to duty’ to battle a deadly global threat
Boston-area researchers are collaborating as part of an international partnership working on a response to the new coronavirus.
-
Health
Coronavirus likely now ‘gathering steam’
Harvard’s Marc Lipsitch said evidence indicates that the international cordon keeping coronavirus cases bottled up in China is a leaky one, and it’s likely that the relative handful of global cases reported so far are undercounted. If true, that will lead to widespread illness internationally, including in the U.S.
-
Health
A solid vaccine for liquid tumors
A new study presents an alternative treatment for acute myeloid leukemia (AML) that has the potential to eliminate AML cells completely.
-
Health
Fears arise that new federal fetal-tissue restrictions will hobble a ‘workhorse’ of research
With the Trump administration halting fetal tissue research at two prominent scientific institutions and new plans to review such research elsewhere, Harvard Medical School Dean George Daley discussed the importance of research using these tissues, which would otherwise be discarded, in creating vaccines and treatments and enhancing our understanding of human biology.
-
Health
Inoculating against misinformation
A new survey by Harvard researchers shows that trust in leaders and institutions are at a low ebb in the eastern Democratic Republic of the Congo, highlighting the importance of gaining trust as part of the response to the growing Ebola epidemic there.
-
Health
Everywhere you look, flu
Answers from Yonatan Grad, an assistant professor of immunology and infectious disease, on why this year’s flu season has been so severe.
-
Health
Study explores whole-body immunity
New research on the immune system suggests that the molecule interferon plays an important role in activating antiviral genes across many tissues, helping against infection.
-
Health
A shot against heart attacks?
Harvard Stem Cell Institute scientists collaborating with researchers at the University of Pennsylvania have developed a “genome-editing” approach for permanently reducing cholesterol levels in mice through a single injection, a development with the potential to reduce the risk of heart attacks in humans by 40 to 90 percent.
-
Health
Vaccine holds promise against ovarian cancer
A novel approach to cancer immunotherapy — strategies designed to induce the immune system to attack cancer cells — may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.
-
Health
Underprepared for the next pandemic
A lack of “surge” capacity plagues pandemic flu preparations around the world, as public health officials, scientists, and pharmaceutical industry scientists work to streamline vaccine production as well as improve surveillance, communication, and other public health practices before the next new ailment hits.
-
Health
Flu’s coming, but which kind?
With a new flu virus appearing in China in April and a new SARS-like respiratory ailment appearing in the Middle East, the Gazette sat down with Harvard epidemiologist Marc Lipsitch to talk about the upcoming flu season.
-
Health
Vaccine works on hard-to-treat leukemia
Scientists at Harvard-affiliated Dana-Farber Cancer Institute observed a strong and selective immune response in some patients who received several doses of a “personalized” tumor vaccine composed of their own inactivated leukemia cells combined with an immune stimulant.
-
Health
A focus on battling tuberculosis
Scientists from around New England gathered at the Broad Institute of MIT and Harvard to discuss the latest research and findings about tuberculosis at the Fifth Annual New England Tuberculosis Symposium.
-
Health
One vaccine for two strains?
Harvard Medical School researchers believe that identifying the properties of the herpes viruses found in Africa could open the door to developing a more potent vaccine against an infection now rampant in sub-Saharan Africa.
-
Health
Plotting the demise of malaria
Authorities on malaria from around the world came to Harvard Medical School to participate in a forum discussing a change in strategy in the battle against malaria, moving from control to eradication.
-
Health
Hope for AIDS vaccine?
Progress on several fronts has raised optimism about the possibility of achieving an effective AIDS vaccine in the coming years, a speaker at the Harvard School of Public Health said Tuesday (Nov. 9).
-
Health
Cancer vaccine success
A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week (Nov. 25) in the journal Science Translational Medicine.
-
Campus & Community
Results of AIDS vaccine trial ‘weak’ in second analysis
In an editorial accompanying the journal paper, Dr. Raphael Dolin of the Beth Israel Deaconess Medical Center in Boston said the overall findings were nonetheless “of potentially great importance to the field of HIV research” because they might yield information about the kinds of immune responses necessary to provide protection against the virus….
-
Campus & Community
Flu, Me? Public Remains Wary Of H1N1 Vaccine
Fewer than half of Americans say that they are planning to receive the new H1N1 swine flu vaccine, according to recent polls — a trend that is leaving many health professionals at a loss. For one thing, there are many different reasons why people say they are unlikely to get vaccinated. Nearly a third are…
-
Health
AIDS research symposium details advances
Harvard AIDS researchers detailed recent advances in the fight against the ongoing global pandemic, including new vaccine strategies, insights into the disease’s progression in the world’s hardest-hit regions, and new knowledge about the body’s immune response against infection.
